Vanguard Group Inc Cortexyme, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Cortexyme, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,214,621 shares of CRTX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,214,621
Previous 1,131,530
7.34%
Holding current value
$1.57 Million
Previous $1.46 Million
7.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CRTX
# of Institutions
49Shares Held
6.26MCall Options Held
101KPut Options Held
400-
Tang Capital Management LLC San Diego, CA1.5MShares$1.94 Million0.24% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA852KShares$1.1 Million0.41% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny484KShares$624,2330.0% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL342KShares$440,6250.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M